Segnos Overview
- Year Founded
-
2024
- Status
-
Private
- Latest Deal Type
-
Seed
- Investors
-
2
Segnos General Information
Description
Operator of a diagnostics company intended to become a global niche leader in magnetic separation and diagnostic materials. The company offers testing technologies using stimulus-responsive magnetic nanoparticles, enabling customers to achieve high-speed and high-sensitivity bio separation for early disease detection.
Contact Information
Website
www.segnos.co.jpCorporate Office
- Chiba Chuo Twin Building Number 2, 7th Floor, Chiba Lab
- 2-5-1 Chuo, Chuo-ku
- Chiba, 260-0013
- Japan
Corporate Office
- Chiba Chuo Twin Building Number 2, 7th Floor, Chiba Lab
- 2-5-1 Chuo, Chuo-ku
- Chiba, 260-0013
- Japan
Segnos Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Seed Round | 22-Oct-2026 | Completed | Generating Revenue | |||
| 1. Grant | Completed | Startup |
Segnos Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BP Capital (Japan) | PE/Buyout | Minority | ||
| Chiba City Industrial Promotion Foundation | Corporation |
Segnos FAQs
-
When was Segnos founded?
Segnos was founded in 2024.
-
Where is Segnos headquartered?
Segnos is headquartered in Chiba, Japan.
-
What industry is Segnos in?
Segnos’s primary industry is Diagnostic Equipment.
-
Is Segnos a private or public company?
Segnos is a Private company.
-
What is Segnos’s current revenue?
The current revenue for Segnos is .
-
Who are Segnos’s investors?
BP Capital (Japan) and Chiba City Industrial Promotion Foundation have invested in Segnos.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process